Pulmonary arterial hypertension trials in Mexico
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Mexico City, Monterrey
- Age
- 18 years and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00 - Phase 3Taking peopleOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Mexico City, Monterrey
- Age
- 18 years to 75 years
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Guadalajara, Mexico City, Monterrey
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - Phase 1/2Taking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Monterrey, San Luis Potosí City
- Age
- 18 years to 100 years
- People
- 232 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06649110 - No phaseTaking peopleREgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)
- Where
- Mexico City
- Age
- 18 years and over
- People
- 170
- Run by
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
See details and how to joinNCT05665556